Elizabeth Cameron, PhD
Dr. Elizabeth Cameron is the Nuclear Threat Initiative’s (NTI) Vice President for Global Biological Policy and Programs and a Senior Fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service at Texas A&M University. Prior to working at NTI, Dr. Cameron served as the Senior Director for Global Health Security and Biodefense on the White House National Security Council (NSC) staff, where she was instrumental in the development and launch of the Global Health Security Agenda.
From 2010 to 2013, Dr. Cameron served as the Office Director for Cooperative Threat Reduction (CTR) and the Senior Advisor for the Assistant Secretary of Defense for the Nuclear, Chemical and Biological Defense programs. In these roles, she oversaw implementation of the geographic expansion of the Nunn‐Lugar CTR program and, as a result, was awarded the Office of the Secretary of Defense Medal for Exceptional Civilian Service. From 2003 to 2010, she oversaw the expansion of Department of State Global Threat Reduction programs and supported the expansion and extension of the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction, a multilateral framework to improve global CBRN security. From 2001 to 2003, she served as a manager of policy research for the American Cancer Society.
After earning her PhD, Dr. Cameron served as an American Association for the Advancement of Science (AAAS) Fellow in the health policy office of Senator Edward M. Kennedy, where she worked on the Patients’ Bill of Rights, medical privacy, and legislation to improve the quality of cancer care. Dr. Cameron holds a PhD in biology from the Human Genetics and Molecular Biology Program at the Johns Hopkins University and a BA in biology from the University of Virginia.
Dennis Carroll, PhD
Dr. Dennis Carroll currently serves as the Director of the U.S. Agency for International Development’s (USAID) Emerging Threats Division. In this position Dr. Carroll is responsible for providing strategic and operational leadership for the Agency’s programs addressing new and emerging disease threats. He provided overall strategic leadership for the Agency’s response to the West Africa Ebola epidemic.
Dr. Carroll was initially detailed to USAID from the U.S. Centers for Disease Control and Prevention as a senior public health advisor in 1991. In 1995 he was named the Agency’s Senior Infectious Diseases advisor, responsible for overseeing the Agency’s programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity Dr. Carroll was directly involved in the development and introduction of a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug resistant malaria, intermittent therapy for pregnant women and “long-lasting” insecticide treated bednets for prevention of malaria. He was responsible for the initial design and development of the President’s Malaria Initiative (PMI). Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza. He currently oversees the Agency’s implementation of the Emerging Threats program in more than 30 countries across Africa and Asia.
Dr. Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a Research Scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria, including the design of PMI, and avian influenza, the 2008 Administrator’s Management Innovation Award for his management of the Agency’s Avian and Pandemic Influenza program, in 2015 USAID’s Distinguished Service Award, and a 2018 Lifetime Achievement Award from Texas A&M University.
Joseph Fair, PhD, MPH
Dr. Joseph Fair is a modern-day international disease detective that travels the world in search of plagues before they become global disasters. In addition, Dr. Fair is a scientist, business entrepreneur, media consultant, and builder and creator of public health programs. He has more than eighteen years of experience in building, sustaining, and nurturing successful research and development programs in more than thirty countries. Fair has authored or coauthored more than forty-five peer reviewed articles on virology, public health, emergency response, and virus hunting in disease “hotspots” around the world. In addition, he works as an international outbreak responder and has been highlighted by 60 Minutes, the cover of the Washington Post, CNN, Al Jazeera, NPR, Vice News, NBC News, and other media outlets.
Dr. Fair currently serves as an Emergency Responder with the International Medical Corps; a Senior Fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service at Texas A&M University; a Senior Fellow at the Smithsonian Institution; and as the founder and proprietor of Virion HLTH. He holds a PhD in molecular biology and a Master of Public Health in tropical medicine from Tulane University and a BS in biology/biological sciences from Loyola University, New Orleans.
Richard J. Golsan, PhD
Dr. Richard Golsan is University Distinguished Professor and Distinguished Professor of French at Texas A&M University and a Senior Fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service at Texas A&M University. In addition, he currently serves as the Director of the France/Texas A&M University Institute (Centre d’Excellence) and as the Editor of South Central Review. His areas of research focus on modern and contemporary France and Europe as well as modern genocides and historical trials.
Dr. Golsan has authored or edited more than a dozen books and published more than 100 articles and book chapters. His latest books are The Vichy Past in France Today: Corruptions of Memory (Lexington Books, 2016) and The Trial That Never Ends: Hannah Arendt’s ‘Eichmann in Jerusalem’ in Retrospect, co-edited with Sarah M. Misemer (University of Toronto Press, 2017). Dr. Golsan has been awarded the Palmes Academiques by the French government. He holds a PhD and an MA in French literature from the University of North Carolina at Chapel Hill and a BA in French and geology from Washington and Lee University.
Peter J. Hotez, MD, PhD
Dr. Peter Hotez currently serves as Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also the Director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. He is a Senior Fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service at Texas A&M University. In addition, he is University Professor at Baylor University and Fellow in Disease and Poverty at the James A. Baker III Institute for Public Policy. Dr. Hotez is an internationally recognized physician-scientist in neglected tropical diseases and vaccine development. As head of the Texas Children’s CVD, he leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, Chagas disease, and SARS/MERS, diseases affecting hundreds of millions of children and adults worldwide. In 2006, at the Clinton Global Initiative, he cofounded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people.
Dr. Hotez served previously as President of the American Society of Tropical Medicine and Hygiene, and he is founding Editor-in-Chief of PLoS Neglected Tropical Diseases. Dr. Hotez has authored more than 400 original papers and is the author of the acclaimed Forgotten People, Forgotten Diseases (ASM Press, 2008) and the recently released Blue Marble Health: An Innovative Plan to Fight Diseases of the Poor amid Wealth (Johns Hopkins University Press, 2016). He is an elected member of the National Academy of Medicine, and in 2011, he was awarded the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the WHO. From 2014 to 2016, he served in the Obama administration as U.S. Envoy, focusing on vaccine diplomacy initiatives between the U.S. government and countries in the Middle East and North Africa.
In 2015, Dr. Hotez emerged as a major national thought leader on the Zika epidemic in the Western Hemisphere and globally. He was among the first to predict Zika’s emergence in the U.S. and is called upon frequently to testify before the U.S. Congress. He served on infectious disease task forces for two consecutive Texas governors. For these efforts, in 2017, he was named by Fortune Magazine as one of the thirty-four most influential people in health care. In addition, as both a vaccine scientist and autism dad, he has led national efforts to defend vaccines and has served as an ardent champion of vaccines, going up against a growing national “antivaxx” threat. He appears frequently on television (including BBC, CNN, Fox News, and MSNBC) and radio as well as in newspaper interviews (including the New York Times, USA Today, Washington Post, and Wall Street Journal). Dr. Hotez holds a PhD in biochemistry from Rockefeller University, an MD from Weil Cornell Medical College, and a BS in molecular biophysics from Yale University.
Rebecca Katz, PhD, MPH
Dr. Rebecca Katz is an associate professor and Co-director of the Center for Global Health Science and Security at Georgetown University and a Senior Fellow at the Scowcroft Institute of International Affairs, Bush School of Government and Public Service at Texas A&M University. Prior to Georgetown, she spent ten years at the George Washington University as an associate professor of Health Policy and Emergency Medicine in the Milken Institute School of Public Health. Her research is focused on global health security, public health preparedness, and health diplomacy. Since 2007, much of her work has focused on the domestic and global implementation of the International Health Regulations (IHR).
Since 2004, Dr. Katz has been a consultant to the Department of State, working on issues related to the Biological Weapons Convention, pandemic influenza, and disease surveillance. Dr. Katz holds a PhD from Princeton University, a Master of Public Health from Yale University, and a BA in political science from Swarthmore College.
Oyewale Tomori, DVM, PhD, FRCPath (UK), FCVSN, FASTMH, FAS (Nigeria), NNOM, NAM
Oyewale Tomori is the immediate past President of the Nigerian Academy of Science, with experience in virology, disease prevention, and control. He was at the University of Ibadan from 1971 to 1994. He later served as the pioneer Vice Chancellor of Redeemer’s University in Nigeria from 2004 to 2011. From 1994 to 2004, he was the virologist for the Africa Region of the World Health Organization (WHO), establishing the African Regional Polio Laboratory Network. In 1981, he was recognized by the U.S. Centers for Disease Control and Prevention (CDC) for contributions to Lassa fever research. In 2002, he received the Nigerian National Order of Merit, the country’s highest award for academic and intellectual attainment and national development. He has authored/coauthored over 150 scientific publications. Dr. Tomori has served or continues to serve on numerous advisory committees, including (nationally) Chair, Lassa Fever Steering Committee; National Laboratory Technical Working Group; Expert Working Group on Polio Eradication and Routine Immunization; and others, and (internationally) WHO SAGE; WHO Africa Regional Polio Certification Committee; WHO Group of Experts on Yellow Fever Disease; Chairman, WHO Yellow Fever Emergency Committee on International Health Regulations; GAVI Board; Vice Chair, U.S. National Academy of Medicine Global Health Risk Framework Commission; and World Bank Interagency Working Group on Financing Preparedness and Response. He is an international member of the U.S. National Academy of Medicine and is currently Chair of the Board of Biovaccines Nigeria Ltd.
Edward You is a Supervisory Special Agent in the FBI’s Weapons of Mass Destruction Directorate and is currently detailed to the U.S. Department of Health and Human Services, Office of National Security. Mr. You’s responsibilities include coordinating and improving FBI and interagency efforts to identify, assess, and respond to biological threats or incidents. He leads efforts to identify and address potential security challenges in emerging biotechnology, such as synthetic biology and the use of big data in engineering biology. His overall goal is to safeguard the scientific community, the life science research enterprise, and the U.S. bioeconomy. Before being promoted to the Weapons of Mass Destruction Directorate, Mr. You was a member of the FBI Los Angeles Field Office Joint Terrorism Task Force and served on the FBI Hazardous Evidence Response Team.
Mr. You has also been directly involved in policy-making efforts with a focus on biosecurity. He served as a Working Group member of the National Security Council Policy Coordinating Committee on Countering Biological Threats and as the FBI Ex Officio member of the National Institutes of Health National Science Advisory Board for Biosecurity. He also had the privilege to serve on two National Academies of Sciences, Engineering, and Medicine Committees, the Institute of Medicine’s Forum on Microbial Threats and the Committee on Science, Technology, and Law’s Forum on Synthetic Biology.
Prior to joining the FBI, Mr. You worked for six years in graduate research focusing on retrovirology and human gene therapy at the University of Southern California, Keck School of Medicine. He subsequently worked for three years at the biotechnology firm AMGEN Inc. in cancer research.